Antecedentes

Multidrug-resistant tuberculosis requires accurate identification of both Mycobacterium tuberculosis complex and antimicrobial resistance-associated markers. In automated molecular workflows, system verification is essential to confirm that the full analytical process performs correctly, from sample processing and nucleic acid extraction to amplification, detection, and interpretation of resistance targets.

Laboratories implementing or verifying MDR-TB assays need external controls that appropriately represent relevant resistance profiles and can be processed in the same manner as clinical specimens. This supports assessment of the complete analytical workflow and increases confidence in the simultaneous detection of tuberculosis and resistance-associated mutations.

Product information

AMPLIRUN® TOTAL MDR-TB Verification & Control Panel is an external sputum control panel developed and validated for the BD MAX™ MDR-TB assay. It is designed to support verification and quality control of automated molecular workflows for the detection of Mycobacterium tuberculosis and mutations associated with resistance to rifampicin and isoniazid.

The panel includes 10 vials: 

  • 2 vials of Mycobacterium tuberculosis
  • 2 vials of rifampicin-resistant Mycobacterium tuberculosis with the rpoB S531L mutation
  • 2 vials of rifampicin-resistant Mycobacterium tuberculosis with the rpoB H526D mutation
  • 2 vials of isoniazid-resistant Mycobacterium tuberculosis with the katG S315T mutation
  • 2 vials of isoniazid-resistant Mycobacterium tuberculosis with the inhA C15T mutation

AMPLIRUN® TOTAL controls are formulated as complete inactivated microorganisms in a sample-like matrix, allowing laboratories to monitor the full analytical process. Their quantified, lyophilized, monodose format supports assay verification and external control standardization in molecular workflows for drug-resistant tuberculosis.

Kit AMPLIRUN TOTAL

PRODUCTS

AMPLIRUN® TOTAL MDR-TB VERIFICATION & CONTROL PANEL

CE
Inactivated Mycobacterium tuberculosis (MTB) cells formulated to mimic human sputum specimen and intended to control sample processing, analysis and detection of Mycobacterium tuberculosis (TB) nucleic acids and genetic markers for drug resistant using the product as an external run control. MBTC027 panel is a 5-member panel; 1 sensitive, 2 rifampicin resistant and 2 isoniacid resistant strains.

Analytes: Mycobacterium tuberculosis

Reference MBTC027
Pack size 10 vials

HOW IT WORKS

negative matrix vertical web

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

O'Sullivan DM, Jones GM, Zolnir-Dovc M, Phillips R, Arthur R, Mtafya B, et al. Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis. Clin Chem. 2026 Jan 7:hvaf178.